What You Should Know:
– Sevaro Health, a company specializing in virtual neurological care secures $39M in Series B funding round led by Valtruis and Intermountain Ventures, with continued support from early investors.
– The new capital will allow Sevaro to accelerate innovation, deepen integrations, and expand its hybrid workforce model to help hospitals address staffing shortages and rising patient demand.
Transform Neurological Care with AI and Virtual Solutions
At the core of Sevaro’s model is Synapse AI, a platform that seamlessly connects hospital teams with virtual specialists throughout the entire patient journey. Sevaro is one of the first in the industry to offer care across the full continuum—from ambulance to ambulatory care—including virtual neurology clinics, rehabilitation expertise, and coordinated care solutions.
For hospitals, Synapse AI acts as an extension of their own workforce, helping to prevent coverage gaps, reduce burnout, and ensure timely, backup coverage through seamless workflow automation. The company’s proven model, which began in neurological care, is now expanding into other specialties like cardiology, infectious disease, behavioral health, and surgery.
Measurable Results and a Promising Future
Hospitals that partner with Sevaro are already seeing significant results. One health system saved over $4 million in its first year by increasing access to virtual neurology care and reducing unnecessary hospital transfers. Partners also report an average of 25 seconds to reach a neurologist, increased referrals, and improved provider satisfaction.
“This funding validates what we’ve believed from day one, that hospitals deserve a model where quality and financial performance go hand in hand,” said Dr. Rajiv Narula, Founder and CEO of Sevaro Health. “Synapse AI isn’t just a solution for coverage, it’s our commitment to building the future of specialty care where physicians are proud to practice, and every patient in the world receives the care they deserve.”
